Announce Date | 08/05/2024 |
EPS Normalized Actual | $0.3104 (Beat by $0.4704) |
EPS GAAP Actual | $0.3104 (Beat by $0.4704) |
Revenue Actual | $0.026852B |
Revenue Surprise | Beat by $26.852M |
Announce Date | 07/01/2024 (Pre-Market) |
EPS Normalized Estimate | $-0.34715 |
EPS GAAP Estimate | $-0.34715 |
Revenue Estimate | $0.067112222B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 0.715 | 41.5 | 0.70332 | 0.72413 | 2 |
Dec 2027 | 0.12 | 247.25 | 0.11804 | 0.12153 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.97 | -0.97 | 0.026852B | 15.04% | 26.85M |
FQ4 2021 (Dec 2021) | -0.25 | -0.25 | 0.025039B | 30.91% | 25.04M |
FQ3 2021 (Sep 2021) | -0.47 | -0.47 | 0.023475B | 35.18% | 23.48M |
FQ2 2021 (Jun 2021) | -0.35 | -0.35 | 0.022758B | 44.13% | 22.76M |
FQ1 2021 (Mar 2021) | -0.17 | -0.17 | 0.022813B | 23.65% | 22.81M |
FQ4 2020 (Dec 2020) | -0.23 | -0.23 | 0.017299B | -1.94% | 17.3M |
FQ3 2020 (Sep 2020) | -0.23 | -0.23 | 0.015217B | 2.91% | 15.22M |
FQ2 2020 (Jun 2020) | -0.08 | -0.08 | 0.012715B | 15.54% | 12.72M |
FQ4 Announce Date
07/01/2024 (Pre-Market)
Consensus EPS Estimates
-0.34715
Consensus Revenue Estimates
0.067112222B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | -0.2224 | -- | -0.22843 | -0.21317 | 3 |
FQ3 2026 (Sep 2026) | -0.3243 | -- | -0.33309 | -0.31084 | 3 |
FQ2 2026 (Jun 2026) | -0.2573 | -- | -0.26427 | -0.24662 | 3 |
FQ1 2026 (Mar 2026) | -0.3991 | -- | -0.40991 | -0.38254 | 3 |
FQ4 2025 (Oct 2025) | -0.465 | -- | -0.47963 | -0.45763 | 0 |
FQ3 2025 (Jul 2025) | -0.51876 | -- | -0.53508 | -0.51054 | 0 |
FQ2 2025 (Jun 2025) | -0.43369 | -- | -0.4593 | -0.39358 | 2 |
FQ1 2025 (Mar 2025) | -0.59999 | -- | -0.63542 | -0.5445 | 2 |
FQ4 2024 (Oct 2024) | -0.63996 | -- | -0.66009 | -0.62982 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.07B | -- | 0.07B | 0.07B | 4 |
FQ3 2026 (Sep 2026) | 0.07B | -- | 0.06B | 0.07B | 4 |
FQ2 2026 (Jun 2026) | 0.07B | -- | 0.07B | 0.07B | 4 |
FQ1 2026 (Mar 2026) | 0.06B | -- | 0.06B | 0.06B | 4 |
FQ4 2025 (Oct 2025) | 0.07B | -- | 0.07B | 0.07B | 0 |
FQ3 2025 (Jul 2025) | 0.06B | -- | 0.06B | 0.07B | 0 |
FQ2 2025 (Jun 2025) | 0.06B | -- | 0.06B | 0.07B | 1 |
FQ1 2025 (Mar 2025) | 0.06B | -- | 0.05B | 0.06B | 1 |
FQ4 2024 (Oct 2024) | 0.06B | -- | 0.06B | 0.06B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.97 | -0.97 | 100% | |
FQ4 2021 (Dec 2021) | -0.25 | -0.25 | 100% | |
FQ3 2021 (Sep 2021) | -0.47 | -0.47 | 100% | |
FQ2 2021 (Jun 2021) | -0.35 | -0.35 | 100% | |
FQ1 2021 (Mar 2021) | -0.17 | -0.17 | 100% | |
FQ4 2020 (Dec 2020) | -0.23 | -0.23 | 100% | |
FQ3 2020 (Sep 2020) | -0.23 | -0.23 | 100% | |
FQ2 2020 (Jun 2020) | -0.08 | -0.08 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0.03B | $26.85M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.03B | $25.04M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.02B | $23.48M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.02B | $22.76M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0.02B | $22.81M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0.02B | $17.3M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0.02B | $15.22M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.01B | $12.72M | 100% |